Teva to Receive $15 Million Tax Credit for Building Research Facility in New Jersey
By Frank L. Brunetti
The Israeli pharmaceutical company Teva is currently weighing the decision to build a large research facility in New Jersey or Pennsylvania, and the former is willing to
sweeten the deal by offering a significant tax credit to the drug maker.
New Jersey has agreed to provide Teva with a $15 million tax credit if signs a contract to build the projected $73 million facility in Florham Park, New Jersey and create 215 jobs in the state, according to the New Jersey Star-Ledger. The job openings would supplement the 300 employees who are currently working in New Jersey at Teva, which is the country’s largest manufacturer of generic medications.
Firefox recommends the PDF Plugin for Mac OS X for viewing PDF documents in your browser.
We can also show you Legal Updates using the Google Viewer; however, you will need to be logged into Google Docs to view them.
Please choose one of the above to proceed!
LOADING PDF: If there are any problems, click here to download the file.